The use of antidepressants to treat attention deficit hyperactivity disorder in adults

Journal of Psychopharmacology

Volumn 17, Issue 3, 2003, Pages 332-336

  Maidment, Ian D ^a  

^a KENT AND CANTERBURY HOSPITAL   (United Kingdom)

Author keywords

Adult ADHD; Antidepressants; Bupropion; Tricyclics; Venlafaxine

Indexed keywords

AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATOMOXETINE; CYCLOHEXANOL DERIVATIVE; DESIPRAMINE; METHYLPHENIDATE; PROPYLAMINE; PSYCHOSTIMULANT AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG; VENLAFAXINE;

ADULT; AGITATION; ANXIETY DISORDER; APPETITE DISORDER; ATTENTION DEFICIT DISORDER; CLINICAL TRIAL; CONFUSION; DRUG EFFICACY; ECG ABNORMALITY; FATIGUE; HEART RATE; HUMAN; INSOMNIA; IRRITABILITY; LONG TERM CARE; NAUSEA; PRIORITY JOURNAL; REVIEW; SEDATION; SIDE EFFECT; SYMPTOMATOLOGY; TREATMENT OUTCOME;

ADULT; ANTIDEPRESSIVE AGENTS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BUPROPION; CLINICAL TRIALS; CYCLOHEXANOLS; HUMANS; PROPYLAMINES;

EID: 0141815717     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/02698811030173016     Document Type: Review

References (28)

1. Adler L A, Resnick S, Kunz M, Devinsky O (1995) Open label trial of venlafaxine in adults with attention deficit hyperactivity disorder. Psychopharmacol Bull 31: 785-788
2. American Psychiatric Association (1987) Diagnostic and statistical manual of mental disorders (DSM-III-R), rev. 3rd edn. American Psychiatric Association, Washington, DC
3. American Psychiatric Association (1994) Diagnostic and statistical manual of mental disorders, (DSM-IV), 4th edn. American Psychiatric Association, Washington, DC
4. Beck A T, Ward C H, Mendelson M, Mock J, Erbaugh J (1961) An inventory for measuring depression. Arch Gen Psychiatry 4: 53-63
5. DuPaul G (1990) The ADHD rating scale: normative data, reliability, and validity. University of Massachusetts Medical School, Worcester
6. DuPaul GJ (1991) Parent and teacher ratings of ADHD symptoms: psychometric properties in a community-based sample. J Clin Child Psychol 20: 245-253
7. DuPaul G, Power T, Anastopoulos A, Reid R (1998) ADHD rating scale IV: checklists, norms and clinical interpretation. Guilford, New York
8. Findling R L, Schwartz M A, Flannery D J, Manos M J (1996) Venlafaxine in adults with attention deficit hyperactivity disorder: an open clinical trial. J Clin Psychiatry 57: 184-189
9. Hamilton M (1959) The assessment of anxiety scales by rating. Br J Med Psychol 32: 50-55
10. Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62
11. Hedges D, Reimherr F W, Rogers A, Strong R, Wender P H (1995) An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol Bull 31: 779-783
12. Kuperman S, Perry P J, Gaffney G R, Lund B C, Bever-Stille K A, Arndt S, Holman T L, Moser D J, Paulsen J S (2001) Bupropion SR versus methylphenidate versus placebo for attention deficit hyperactivity disorder in adults. Ann Clin Psychiatry 13: 129-134
13. Mannuzza S, Klein R G, Bessler A, Malloy P, LaPadula M (1998) Adult psychiatric status of hyperactive children grown up. Am J Psychiatry 155: 493-498
14. Mattes J A, Boswell L, Oliver H (1984) Methylphenidate effects on symptoms of attention deficit disorder in adults. Arch Gen Psychiatry 41: 1059-1063
15. National Institute of Mental Health (1985) CGI (Clinical Global Impression) scale. Psychopharmacol Bull 21: 839-843
16. Reimherr F W, Hedges D W, Strong R E (1995) An open trial of venlafaxine in adult patients with attention deficit hyperactivity disorder. Psychopharmacol Bull 31: 609
17. Shaffer D (1994) Attention deficit hyperactivity disorder in adults. Am J Psychiatry 154: 633-638
18. Shekim W O, Asarnow R F, Hess E, Zaucha K, Wheeler N (1990) A clinical and demographic profile of a sample of adults with attention deficit hyperactivity disorder, residual state. Compr Psychiatry 31: 416-425
19. Spencer T, Wilens T, Biederman J (1995) A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 52: 434-443
20. Spencer T, Biederman J, Wilens T, Prince J, Hatch M, Jones J, Harding M, Faraone S V, Seidman L (1998) Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. Am J Psychiatry 155: 693-695
21. Ward M F, Wender P H, Reimherr F W (1993) The Wender Utah rating scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. Am J Psychiatry 150: 885-890
22. Weiss G, Hechtman L, Milroy T, Perlman T (1985) Psychiatric status of hyperactives as adults: a controlled prospective 15-year follow-up of 63 hyperactive children. J Am Acad Child Psychiatry 24: 211-220
23. Wender P H (1995) Attention-deficit hyperactivity disorder in adults. Oxford University Press, New York
24. Wender P H, Reimherr F W (1990) Bupropion treatment of attention-deficit hyperactivity disorder in adults. Am J Psychiatry 147: 1018-1020
25. Wender P H, Reimherr F W, Wood D (1981) Attention deficit disorder ('minimal brain dysfunction') in adults. Arch Gen Psychiatry 3: 449-56
26. Wilens T E, Biederman J, Mick E, Spencer T J (1995) A systematic assessment of tricyclic antidepressants in the treatment of adult attention-deficit hyperactivity disorder. J Nerv Ment Dis 183: 48-50
27. Wilens T E, Biederman J, Prince J, Spencer T J, Faraone S V, Warburton R, Schleifer D, Harding M, Linehan C, Geller D (1996) Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. Am J Psychiatry 153: 1147-1153
28. Wilens T E, Spencer T J, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux M C, Parekh A (2001) A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. Am J Psychiatry 158: 282-288